Literature DB >> 8388503

Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism.

C Wang1, P Sarnow, A Siddiqui.   

Abstract

The human hepatitis C virus (HCV) contains a long 5' noncoding region (5' NCR). Computer-assisted and biochemical analyses suggest that there is a complex secondary structure in this region that is comparable to the secondary structures that are found in picornaviruses (E.A. Brown, H. Zhang, L.-H. Ping, and S.M. Lemon, Nucleic Acids Res. 20:5041-5045, 1992). Previous in vitro studies suggest that the HCV 5' NCR plays an important role during translation (K. Tsukiyama-Kohara, N. Iizuka, M. Kohara, and A. Nomoto, J. Virol. 66:1476-1483, 1992). Dicistronic and monocistronic expression vectors, in vitro translation, RNA transfections, and deletion mutagenesis studies were utilized to demonstrate unambiguously that the HCV 5' NCR is involved in translational control. Our data strongly support the conclusion that an internal ribosome entry site exists within the 5' noncoding sequences proximal to the initiator AUG. Furthermore, our results suggest that the HCV genome is translated in a cap-independent manner and that the sequences immediately upstream of the initiator AUG are essential for internal ribosome entry site function during translation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388503      PMCID: PMC237677     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  A simple phase-extraction assay for chloramphenicol acyltransferase activity.

Authors:  B Seed; J Y Sheen
Journal:  Gene       Date:  1988-07-30       Impact factor: 3.688

3.  Inactivation of cap-binding proteins accompanies the shut-off of host protein synthesis by poliovirus.

Authors:  K A Lee; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

4.  Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo.

Authors:  S K Jang; M V Davies; R J Kaufman; E Wimmer
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

5.  Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups.

Authors:  R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  5' end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5' untranslated region.

Authors:  B J Yoo; R R Spaete; A P Geballe; M Selby; M Houghton; J H Han
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

7.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

8.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

9.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  178 in total

1.  Novel fluorescence-based screen to identify small synthetic internal ribosome entry site elements.

Authors:  A Venkatesan; A Dasgupta
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Structure and function of a cap-independent translation element that functions in either the 3' or the 5' untranslated region.

Authors:  L Guo; E Allen; W A Miller
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

3.  Natural variation in translational activities of the 5' nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site.

Authors:  M Honda; R Rijnbrand; G Abell; D Kim; S M Lemon
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 4.  Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics.

Authors:  N Usman; L M Blatt
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

5.  Molecular biology of liver disorders:the hepatitis C virus and molecular targets for drug development.

Authors:  Howard J Worman; Feng Lin
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

6.  The internal ribosome entry site (IRES) of hepatitis C virus visualized by electron microscopy.

Authors:  L P Beales; D J Rowlands; A Holzenburg
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

7.  Ribosomal proteins mediate the hepatitis C virus IRES-HeLa 40S interaction.

Authors:  Geoff A Otto; Peter J Lukavsky; Alissa M Lancaster; Peter Sarnow; Joseph D Puglisi
Journal:  RNA       Date:  2002-07       Impact factor: 4.942

8.  Structure of the three-way helical junction of the hepatitis C virus IRES element.

Authors:  Jonathan Ouellet; Sonya Melcher; Asif Iqbal; Yiliang Ding; David M J Lilley
Journal:  RNA       Date:  2010-06-25       Impact factor: 4.942

9.  Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor.

Authors:  Akiko Yanagiya; Seii Ohka; Noriyasu Hashida; Masahito Okamura; Choji Taya; Nobuhiko Kamoshita; Kuniko Iwasaki; Yukari Sasaki; Hiromichi Yonekawa; Akio Nomoto
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 10.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.